Newport Beach, CA5 Active Studies

Head and Neck Cancer Clinical Trials in Newport Beach, CA

Find 5 actively recruiting head and neck cancer clinical trials in Newport Beach, CA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
891
Enrolling

Recruiting Head and Neck Cancer Studies in Newport Beach

RecruitingNewport Beach, CANCT04892173

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab ...

500 participants
Johnson & Johnson Enterprise Innovation Inc.
View Study Details
RecruitingNewport Beach, CANCT06029270

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurre...

156 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNewport Beach, CANCT06532279

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

This phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis in patients who are receiving chemoradiat...

98 participants
NRG Oncology
View Study Details
RecruitingNewport Beach, CANCT04291105

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separ...

87 participants
Vyriad, Inc.
View Study Details
RecruitingNewport Beach, CANCT05904080

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of impro...

50 participants
National Cancer Institute (NCI)
View Study Details

About Head and Neck Cancer Clinical Trials in Newport Beach

Head and neck cancers develop in the mouth, throat, larynx, sinuses, or salivary glands. HPV-related oropharyngeal cancers have been increasing in prevalence. Treatment includes surgery, radiation, chemotherapy, and immunotherapy.

There are currently 5 head and neck cancer clinical trials recruiting participants in Newport Beach, CA. These studies are seeking a combined 891 participants. Research is being sponsored by Johnson & Johnson Enterprise Innovation Inc., National Cancer Institute (NCI), NRG Oncology and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Head and Neck Cancer Clinical Trials in Newport Beach — FAQ

Are there head and neck cancer clinical trials in Newport Beach?

Yes, there are 5 head and neck cancer clinical trials currently recruiting in Newport Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What head and neck cancer treatments are being tested?

The 5 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for head and neck cancer.

Data updated March 2, 2026 from ClinicalTrials.gov